reference/27604108

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27604108

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	2408
issn	0923-7534
issueIdentifier	9
pageRange	2399-2408
publicationName	Annals of Oncology
startingPage	2399
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_111f1b6e0633f44904ff6b8dcef97de6
bibliographicCitation	Markman B, Tabernero J, Krop I, Shapiro GI, Siu L, Chen LC, Mita M, Melendez Cuero M, Stutvoet S, Birle D, Anak Ö, Hackl W, Baselga J. Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors. Ann Oncol. 2012 Sep;23(9):2399–408. doi: 10.1093/annonc/mds011. PMID: 22357447.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9445fbde3c3eea2d6bd6a2768f35e635 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8bb63d4b11a4df6e2ddc73854ea97fe8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eecb781f726cda06e86e4a442af3fb32 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7744a53c92732ea87dd50860f1987a4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e61fdd9651f32d0b27a94802435ab85 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36143345f598bde0e88c80f1b497a461 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9178818ec98407fa0bf4a1aa945eac62 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26a71aee417e4f250b225dae2fcf99d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e103ee3a56f6344be4051c21c7cb62d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06198a22bef77675c983bab09c59b84d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e0ae13e46add19c23a6f3aad0848100 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a081f2b715a116a542b7d44f8b45842b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80ae546e4f700faed260ff8817305348
date	201209
identifier	https://pubmed.ncbi.nlm.nih.gov/22357447 https://doi.org/10.1093/annonc/mds011
isPartOf	https://portal.issn.org/resource/ISSN/0923-7534 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1846
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors
discusses	http://id.nlm.nih.gov/mesh/M0300883 http://id.nlm.nih.gov/mesh/M0572068 http://id.nlm.nih.gov/mesh/M0028704 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0543256 http://id.nlm.nih.gov/mesh/M000649677 http://id.nlm.nih.gov/mesh/M0011048 http://id.nlm.nih.gov/mesh/M0029360 http://id.nlm.nih.gov/mesh/M0018350 http://id.nlm.nih.gov/mesh/M0469193
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID450503 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11418 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66870970 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11978790 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8483 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_78edc8e186d4ca89a5d99640d0f188ad http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11469444 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57336745

Incoming Links

Predicate	Subject
citesAsDataSource	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID249565634_AID1345778_PMID22357447_VALUE20 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID249565634_AID1345786_PMID22357447_VALUE15 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID249565634_AID1345749_PMID22357447_VALUE49
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5290 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248184126 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5294 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID249565634

Total number of triples: 64.